IMIDAZO 1,2-A]PYRIDINES FOR THE TREATMENT OF CNS AND CARDIAC DISEASES
申请人:PHARMACIA & UPJOHN COMPANY
公开号:EP0809642A1
公开(公告)日:1997-12-03
US6013654A
申请人:——
公开号:US6013654A
公开(公告)日:2000-01-11
[EN] IMIDAZO[1,2-A]PYRIDINES FOR THE TREATMENT OF CNS AND CARDIAC DISEASES<br/>[FR] IMIDAZO[1,2-A]PYRIDINES POUR LE TRAITEMENT DU SNC ET DE CARDIOPATHOLOGIES
申请人:PHARMACIA & UPJOHN COMPANY
公开号:WO1996025414A1
公开(公告)日:1996-08-22
(EN) The present invention relates to imidazo[1,2-a]pyridine compounds of formula (I), which are dopamine D-4 antagonists and useful as anti-psychotic agents.(FR) La présente invention concerne des composés imidazo[1,2-a]pyridine de formule I antagonistes de la dopamine D-4 et efficaces comme neuroleptiques.
Imidazo\x9b1,2-a!pyridines for the treatment of CNS and cardiac diseases
申请人:Pharmacia & Upjohn Company
公开号:US05912246A1
公开(公告)日:1999-06-15
The present invention relates to imidazo\x9b1,2-a!pyridine compounds of formula (1) ##STR1## which are dopamine D-4 antagonists and useful as anti-psychotic agents.